Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Temasek buys Rs 1,000...

    Temasek buys Rs 1,000 crore stake in Manipal Hospitals

    Written by Ruby Khatun Khatun Published On 2017-09-19T18:11:29+05:30  |  Updated On 19 Sept 2017 6:11 PM IST
    Temasek buys Rs 1,000 crore stake in Manipal Hospitals

    Mumbai: Temasek Holding, a Singapore based company has agreed to acquire a stake in Manipal hospitals worth Rs 1,000 crore. A transaction has been approved last week by the Temasek’s investment committee to buy True North’s 16% stake in Manipal Health Systems. The move values Manipal at $1 billion, or Rs 6,500 crore a recent report in TOI states.


    It is reported that with the investment Temasek will join TPG Capital, another global investor owning 22%, a significant minority shareholder in Manipal Hospitals.


    True North had also acquired controlling interest in KIMS Hospitals last year which has the network in southern India and the Arabian Gulf. True North also has minority shares in Aster DM Healthcare, which it plans to exit through an IPO later this fiscal.


    Read also: Kerala Institute of Medical Sciences gets Rs 1300 crore investment from True North

    Manipal could become an engine for consolidation in the hospitals business with TPG and Temasek jointly owning about 40% stake in it. TPG in the past has been following Fortis Healthcare acquisitions closely reports TOI.


    Read also: TPG offers Rs 3000 crore for Fortis stake, Daiichi moves court

    Spearheaded by billionaire Ranjan Pai, 43, also the principal shareholder, privately held Manipal Health Enterprises Pvt Ltd (MHEPL) runs the eponymous multi-speciality hospital network and is part of the Bengaluru-headquartered Manipal Education and Medical Group.


    Manipal Health Enterprises Private Limited operates a network of healthcare establishments in India and overseas.Private equity investors such as IDFC and Kotak Mahindra PE were early investors in Manipal.


    Earlier, Temasek has backed Medanta, Apollo Hospitals, and oncology specialists HCG.


    Manipal Hospital has a total of 56 specialties offered under one roof to bring in enhanced health delivery for the patients. The hospital is fast becoming a preferred destination for patients from over 30 countries.


    Read also: Temasek eyes to acquire 18 percent stake in Manipal Healthcare

    AcquisitionacquisitionsAster DM HealthcarebuysFortisFortis HealthcarehospitalIPOKIMS HospitalsManipal Health SystemsManipal HospitalsMedantaNaresh TrehanstakeTemasekTemasek HoldingTemasek Holdings SingaporeTPG capitalTrue NorthWHO
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok